153 related articles for article (PubMed ID: 32458231)
21. Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer.
Hoshino I; Nagata M; Takiguchi N; Nabeya Y; Ikeda A; Yokoi S; Kuwajima A; Tagawa M; Matsushita K; Satoshi Y; Hideaki S
Cancer Sci; 2017 Mar; 108(3):308-315. PubMed ID: 28064445
[TBL] [Abstract][Full Text] [Related]
22. Serum p53 antibodies in correlation to other biological parameters of breast cancer.
Sangrajrang S; Arpornwirat W; Cheirsilpa A; Thisuphakorn P; Kalalak A; Sornprom A; Soussi T
Cancer Detect Prev; 2003; 27(3):182-6. PubMed ID: 12787724
[TBL] [Abstract][Full Text] [Related]
23. Serum anti-p53 antibody detection in carcinomas and the predictive values of serum p53 antibodies, carcino-embryonic antigen and carbohydrate antigen 12-5 in the neoadjuvant chemotherapy treatment for III stage non-small cell lung cancer patients.
Yu DH; Li JH; Wang YC; Xu JG; Pan PT; Wang L
Clin Chim Acta; 2011 May; 412(11-12):930-5. PubMed ID: 21277290
[TBL] [Abstract][Full Text] [Related]
24. Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery.
Yamashita K; Makino T; Tanaka K; Yamasaki M; Yamamoto M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
World J Surg; 2017 Jun; 41(6):1566-1574. PubMed ID: 28108772
[TBL] [Abstract][Full Text] [Related]
25. Prognostic values of normal preoperative serum cancer markers for gastric cancer.
Feng F; Sun L; Liu Z; Liu S; Zheng G; Xu G; Guo M; Lian X; Fan D; Zhang H
Oncotarget; 2016 Sep; 7(36):58459-58469. PubMed ID: 27533455
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of autoantibodies against Ras-like GTPases, RalA, in patients with gastric cancer.
Nanami T; Hoshino I; Ito M; Yajima S; Oshima Y; Suzuki T; Shiratori F; Nabeya Y; Funahashi K; Shimada H
Mol Clin Oncol; 2020 Oct; 13(4):28. PubMed ID: 32765875
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Funami Y; Shiratori T; Hayashi H; Takeda A; Ochiai T
Surgery; 2002 Jul; 132(1):41-7. PubMed ID: 12110794
[TBL] [Abstract][Full Text] [Related]
28. Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers.
Nanami T; Hoshino I; Shiratori F; Yajima S; Oshima Y; Suzuki T; Ito M; Hiwasa T; Kuwajima A; Shimada H
Int J Clin Oncol; 2022 Jan; 27(1):72-76. PubMed ID: 34632560
[TBL] [Abstract][Full Text] [Related]
29. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
[TBL] [Abstract][Full Text] [Related]
30. p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis.
Sobhani N; Roviello G; D'Angelo A; Roudi R; Neeli PK; Generali D
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684792
[No Abstract] [Full Text] [Related]
31. Long-term monitoring of serum p53 antibody after neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: report of a case.
Shimada H; Nagata M; Cho A; Takiguchi N; Kainuma O; Soda H; Ikeda A; Nabeya Y; Yajima S; Yamamoto H; Sugiyama T; Itami M
Surg Today; 2014 Oct; 44(10):1957-61. PubMed ID: 24241479
[TBL] [Abstract][Full Text] [Related]
32. The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.
Kawahara D; Fujita F; Hayashi H; Matsuyama T; Eguchi S
Hepatogastroenterology; 2015 May; 62(139):624-8. PubMed ID: 26897942
[TBL] [Abstract][Full Text] [Related]
33. Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.
Ushigome M; Shimada H; Miura Y; Yoshida K; Kaneko T; Koda T; Nagashima Y; Suzuki T; Kagami S; Funahashi K
Int J Clin Oncol; 2020 Apr; 25(4):622-632. PubMed ID: 31820210
[TBL] [Abstract][Full Text] [Related]
34. Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases.
Neri M; Betta P; Marroni P; Filiberti R; Cafferata M; Mereu C; Ivaldi G; Montanaro F; Puntoni R; Paganuzzi M
Lung Cancer; 2003 Feb; 39(2):165-72. PubMed ID: 12581569
[TBL] [Abstract][Full Text] [Related]
35. Stage-Specific Alteration and Prognostic Relationship of Serum Fumarate Hydratase Autoantibodies in Gastric Cancer.
Sasajima N; Sumazaki M; Oshima Y; Ito M; Yajima S; Takizawa H; Wang H; Li SY; Zhang BS; Yoshida Y; Hiwasa T; Shimada H
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791507
[TBL] [Abstract][Full Text] [Related]
36. Anti-FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer.
Kobayashi S; Hiwasa T; Ishige T; Kano M; Hoshino T; Rahmutulla B; Seimiya M; Shimada H; Nomura F; Matsubara H; Matsushita K
Cancer Sci; 2021 Feb; 112(2):847-858. PubMed ID: 33306856
[TBL] [Abstract][Full Text] [Related]
37. [Serum anti-p53 antibodies in gastric cancer patients].
Lawniczak M; Bielicki D; Sulzyc-Bielicka V; Marlicz K; Starzyńska T
Pol Merkur Lekarski; 2007 Sep; 23(135):192-5. PubMed ID: 18080693
[TBL] [Abstract][Full Text] [Related]
38. Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group.
Shimada H; Ochiai T; Nomura F;
Cancer; 2003 Feb; 97(3):682-9. PubMed ID: 12548611
[TBL] [Abstract][Full Text] [Related]
39. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
